Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Smith & Nephew FDA Approved on Bone Healer - Medical Product Outsourcing

Smith & Nephew FDA Approved on Bone Healer

Orthopedic device manufacturer Smith & Nephew has been approved by the FDA to market its Exogen 4000+ bone-healing system in the US. The Exogen 4000+ — intended as a replacement to the company’s predecessor Exogen 2000+ — has been shown to accelerate the healing of certain fractures by 38% and to heal 86% of hard-to-heal bone fractures, according to Smith & Nephew officials.
    The Exogen 4000+ is first low-intensity, pulsed ultrasound bone stimulator to use ultrasound approved to treat broken bone that has failed to heal properly.
    “Receiving FDA approval for the EXOGEN 4000+ Bone Healing System is yet another win for surgeons and patients,” said Ken Reali, vice president and general manager, Orthopaedic Clinical Therapies. “While the accelerated healing potential and non-union treatment capabilities of the system continue to provide the same non-invasive alternative to surgery, the design upgrades make it easier to operate further optimizing patient care.”
    The Memphis, TN-based division said it would launch the new system in the United States and overseas this fall.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters